AIM2 and hepatocellular carcinoma: The AIM2 inflammasome can weaken the activation of S6K1 by targeting mTOR, thus inhibiting the growth of cancer cells, and the accumulation of the AIM2 inflammasome can cause HCC cells pyroptosis, exerting antitumor effects53,54.